Clinical Trials Logo

Mental Disorders clinical trials

View clinical trials related to Mental Disorders.

Filter by:

NCT ID: NCT05321355 Recruiting - Insomnia Clinical Trials

Mainz Register of Patients With Sleep Disorders

MAINZ-SLEEPREG
Start date: February 1, 2022
Phase:
Study type: Observational [Patient Registry]

Prospective longitudinal observational registry study of all patients with sleep disorders treated in the Mainz Comprehensive Epilepsy and Sleep Medicine Center with the focus on the course of the disease and quality of life.

NCT ID: NCT05320991 Completed - Social Cognition Clinical Trials

Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers

METAKETAII
Start date: June 15, 2019
Phase: Phase 4
Study type: Interventional

Antipsychotic medication shows generally good effect sizes when looking at reduction of positive psychotic symptoms of schizophrenia, such as paranoia or delusion. However, social functioning often remains deficient in patients, meaning dopamine-receptor antagonists are not sufficient in treatment of people with schizophrenia. A naturalistic video-based paradigm, named MASC has been used in the past to model over- and undermentalizing in patients with autism spectrum disorder and schizophrenia, since deficits in mentalizing can be explained by either overinterpreting a social situation (e.g. paranoid thoughts about intentions of others towards self) or by lacking the skill to read intentions of others. To find out whether experimental manipulation via a non-competetive N-methyl-D-aspartate antagonist can induce difficulties with social cognition similar to those observed in people with schizophrenia, the investigators will conduct a RCT applying either ketamine or a placebo intravenously while participants are completing the above mentioned mentalizing task in the fMRI-scanner.

NCT ID: NCT05318976 Recruiting - Alzheimer Disease Clinical Trials

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

MINDFuL
Start date: February 28, 2022
Phase: Phase 2
Study type: Interventional

The goal of this Phase 2 Alzheimer's study is to determine whether 1.0 mg/kg XPro1595 confers a benefit on cognition, function, and biomarkers of white matter and to further evaluate safety and tolerability. The objectives of this study are to determine the safety, tolerability, and efficacy of XPro1595 in patients with early ADi.

NCT ID: NCT05316948 Not yet recruiting - Mental Health Issue Clinical Trials

Mental Health and Sexuality in Adolescents and Young Adults

SEX-T-ADO
Start date: September 2022
Phase:
Study type: Observational

According to the World Health Organization (WHO), "Sexual health is a state of physical, emotional, mental and social well-being in relation to sexuality, not merely the absence of disease, dysfunction or of infirmity. Sexual health requires a positive and respectful approach to sexuality and sexual relationships [...]". The main objective is to show that a training intervention intended for psychiatric care teams and targeted on the question of the impact of psychiatric disorders and psychotropic drugs on the sexuality of young people, increases the proportion of young people with whom the question of sexual health is discussed (in connection with psychiatric disorders and, if applicable, with the taking of psychotropic treatment, while they are hospitalized for a psychiatric disorder in the clinics of the FSEF and receive, or not, psychotropic treatment ).

NCT ID: NCT05315609 Not yet recruiting - Stress Clinical Trials

Effects of Virtual Reality Meditation in Older Adults

Start date: April 2022
Phase: N/A
Study type: Interventional

Virtual reality (VR) allows users to interact within a simulated environment using electronic devices such as a VR headset or goggles. Multiple studies with younger adults have demonstrated that VR meditation can be an important tool in reducing stress, however, this has not been studied in older adults. In this study, the investigators aim to assess the effects of a 4-week program of 15-minutes sessions, twice per week of meditation delivered through VR with the aim of evaluating its impact on stress in older adults.

NCT ID: NCT05314153 Recruiting - Clinical trials for Postpartum Psychosis

Effects Zulresso on Postpartum Psychosis

Start date: February 23, 2022
Phase: Early Phase 1
Study type: Interventional

This is an open-label, proof of concept trial to investigate the efficacy, safety and tolerability of Zulresso (brexanolone) administered to adult female subjects diagnosed with postpartum psychosis. This study will provide critical pilot data to determine whether there is similar treatment efficacy among patients with postpartum psychosis as observed to date in patients with postpartum depression.

NCT ID: NCT05310838 Recruiting - Clinical trials for First Episode Psychosis

Optimizing Engagement in Services for First-Episode Psychosis

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This study will compare a 12-session behavioral activation (BA) intervention modified for first-episode psychosis (FEP) to usual community mental health care (i.e., treatment-as-usual; TAU) delivered over 6 months with a sample of Latinos with FEP and their families. Comparable family group sessions will also be delivered to participants in both conditions. It is expected that BA participants will show better engagement than TAU participants.

NCT ID: NCT05309577 Recruiting - Alzheimer Disease Clinical Trials

Self-Care for Dementia Caregivers

Care2
Start date: March 7, 2023
Phase: N/A
Study type: Interventional

The Self-care for Dementia Caregivers Study is a behavioral health intervention that uses digital monitoring tools and motivational health coaching to help caregivers of persons with dementia engage in a regular routine of self-care. Participants wear an apple watch for the objective collection of sleep-wake rhythms. They receive personalized feedback on their sleep-wake rhythms via a new app. Health coaches call participants weekly, for 6 weeks to help participants meet their health/sleep goals and promote self-knowledge of regular routines. Participants will help the study team improve the design elements and content of the mobile app. The goal of this intervention is to reduce psychological distress and caregiver burden.

NCT ID: NCT05308056 Completed - Psychotic Disorders Clinical Trials

Depth of Anesthesia During Electroconvulsive Therapy

ACDC
Start date: April 19, 2022
Phase:
Study type: Observational

Aim: To describe anesthetic depth using spectal edge frequency (SEF) and density spectral array (DSA) and its relation to treatment effect of electroconvulsive therapy (ECT). Study design: Observational study Primary outcomes: SEF, DSA and treatment effect of ECT. Method: SEF and DSA si measured using a commercially available monitor for depth of anesthesia. Treatment effect of ECT will be evaluated using hemodynamic, electroencephalographic and clinical variables.

NCT ID: NCT05307770 Terminated - Parkinson Disease Clinical Trials

Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this research is to compare the efficacy of immediate versus extended-release melatonin as a supplement affecting the sleep cycle in patients with Parkinson disease and Rapid Eye Movement Sleep Behavior Disorder.